Webinars

• Filling Critical Unmet Need in Psoriatic Arthritis and Ankylosing Spondylitis: European Physician and Payer Insights on New Market Entrants - On Demand
  January 26, 2012
  Based on our European Physician & Payer Forum report entitled How Will New Entrants Alter the Biologics Landscape in Ankylosing Spondylitis and Psoriatic Arthritis? A European Physician and Payer Perspective, Decision Resources is offering this exclusive webinar.
  
  This webinar was recorded live on on January 26, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• European Physician and Payer Perspectives on Immune-Targeted Agents in Rheumatoid Arthritis - On Demand
  January 19, 2012
  Based on our European Physician & Payer Forum report entitled What are European Physician and Payer Expectations for the Uptake of Emerging Oral Immunomodulators in Rheumatoid Arthritis?, Decision Resources is offering this exclusive webinar.
  
  This webinar was recorded live on January 19, 2012.  Contact us to learn how you can access the recorded playback of this event.
  
  Click here to view the invite.

   

  Read More
• Physician and Payer Perspectives on Molecular Management and Maintenance Treatment of NSCLC: Maximizing Market Access Opportunities in the EU5 - Upcoming
  December 16, 2011
  Based on our European Physician & Payer Forum report entitled Molecularly Driven Management and Maintenance Treatment of NSCLC: Physician and Payer Perspectives on the Changing Treatment Paradigms in Europe, Decision Resources is offering this exclusive webinar.
  
  This webinar will be held on December 16, 2011.
  
  Click here to view the invite.

   

  Read More
• What are the Implications of the Recently Announced Patent for Amgen’s Enbrel on the Biosimilar Market Amongst TNF-α Inhibitors? - On Demand
  December 15, 2011
  As part of our Biosimilars Advisory Service, Decision Resources is offering this exclusive webinar.
  
  This webinar was recorded live on December 15, 2011.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Multiple Sclerosis: Neurologist and Payer Receptivity to Gilenya, Tysabri and Late-Stage Emerging Agents that Could Reshape the Treatment Algorithm - On Demand
  December 14, 2011
  Based on our U.S. Physician & Payer Forum report Physician and Payer Attitudes Towards Gilenya and Emerging Oral and Parenteral Disease-Modifying Therapies in the U.S. Multiple Sclerosis Market, Decision Resources is offering this exclusive webinar.
  
  This webinar was recorded live on December 14, 2011. Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Alzheimer’s Disease: How Will the Emerging and Potentially Disease-Modifying Therapies Solanezumab, Bapineuzumab and Gammagard Impact Treatment and Reimbursement? - On Demand
  December 13, 2011
  Based on our U.S. Physician & Payer Forum report entitled Physician and Payer Insights on the Impact of Emerging Therapies and Generic Donepezil on the U.S. Alzheimer’s Disease Market, Decision Resources is offering this exclusive webinar.
  
  This webinar was recorded live on December 13, 2011.  Contact us to access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Prescribing and Reimbursement of Targeted Therapies in Europe – How Will the Battle for Patient Share Evolve in the Lucrative Breast Cancer Drug Market? - On Demand
  December 9, 2011
  Based on our European Physician & Payer Forum report entitled Positioning of Current and Emerging Targeted Agents in Breast Cancer: Physician & Payer Perspective on Treatment and Reimbursement Decisions in Europe, Decision Resources is offering this exclusive webinar.
  
  This webinar was recorded live on December 9, 2011.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• U.S. Physician and Payer Insights on Key Emerging Agents in the Increasingly Competitive Psoriasis Drug Market - On Demand
  December 7, 2011
  Based on our U.S. Physician & Payer Forum report entitled U.S. Physician and Payer Perspectives on Emerging Immunomodulators in Psoriasis, Decision Resources is offering this exclusive webinar.
  
  This webinar was recorded live on December 7, 2011.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Atrial Fibrillation: U.S. Physician and Payer Perceptions Regarding New Anticoagulants - On Demand
  December 6, 2011
  Based on our U.S. Physician & Payer Forum report entitled Pradaxa, Xarelto, and Eliquis for Atrial Fibrillation: How Have Phase III Data Informed Physician and Payer Perceptions of These New Anticoagulants?, Decision Resources is offering this exclusive webinar.
  
  This webinar was recorded live on December 6, 2011.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Clinical Strategies to Maximize the Commercial Significance of Your Biosimilar for Oncology Indications - On Demand
  November 28, 2011
  Decision Resources is offering an exclusive webinar based on findings from Biosimilars Advisory Service: Physician Perspectives on Biosimilar G-CSFs and MAbs in Oncology.
  
  This webinar was recorded live on November 28, 2011. Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
Displaying results 1-10 (of 121)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >|